Prognostic significance of recurring chromosomal abnormalities in transplanted patients with acute myeloid leukemia-Reference-Cited by-同舟云学术

Prognostic significance of recurring chromosomal abnormalities in transplanted patients with acute myeloid leukemia

Published:2019-03-07 Issue:8 Volume:33 Page:1944-1952
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Canaani Jonathan,Labopin Myriam,Itälä-Remes Maija,Blaise Didier^ORCID,Socié Gerard^ORCID,Forcade Edouard,Maertens Johan,Wu Depei,Malladi Ram,Cornelissen Jan J.,Huynh Anne,Bourhis Jean Henri,Esteve Jordi,Mohty Mohamad,Nagler Arnon

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/s41375-019-0439-3.pdf

Reference49 articles.

1. Ding L, Ley TJ, Larson DE, Miller CA, Koboldt DC, Welch JS, et al. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature. 2012;481:506–10.

2. Welch JS, Ley TJ, Link DC, Miller CA, Larson DE, Koboldt DC, et al. The origin and evolution of mutations in acute myeloid leukemia. Cell. 2012;150: 264–78.

3. Cancer Genome Atlas Research N, Ley TJ, Miller C, Ding L, Raphael BJ, Mungall AJ, et al. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013;368:2059–74.

4. Shlush LI, Zandi S, Mitchell A, Chen WC, Brandwein JM, Gupta V, et al. Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia. Nature. 2014;506:328–33.

5. Lindsley RC, Mar BG, Mazzola E, Grauman PV, Shareef S, Allen SL, et al. Acute myeloid leukemia ontogeny is defined by distinct somatic mutations. Blood. 2015;125:1367–76.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of Newly Customized Myeloid NGS Panel in the Diagnosis of Myeloid Malignancies;International Journal of General Medicine;2024-01

2. Cord blood transplantation for AML: Comparable LFS in patients with de novo versus secondary AML in CR1, an ALWP/EBMT study;British Journal of Haematology;2023-10-02

4. Impact of Cytogenetic Risk on Outcomes of Non-T-Cell–Depleted Haploidentical Hematopoietic Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia;Transplantation and Cellular Therapy;2022-11

5. Cytogenetics analysis as the central point of genetic testing in acute myeloid leukemia (AML): a laboratory perspective for clinical applications;Clinical and Experimental Medicine;2022-10-13